Projects per year
Personal profile
Personal profile
Tetsuo Ashizawa, MD, formerly the executive director of the McKnight Brain Institute at the University of Florida, organized and developed interdisciplinary neuroscience research programs involving multiple colleges and departments. He also chaired the neurology department at the University of Texas Medical Branch and at the University of Florida, where he supervised the clinical care of and research in a variety of neurological disorders.
As a physician-scientist, some of Dr. Ashizawa’s current research is funded by the National Institutes of Health, the Muscular Dystrophy Association and the Myotonic Dystrophy Foundation. He is studying neurogenetic disorders caused by expansions of DNA sequences that are connected end-to-end and abnormally repeated, such as myotonic dystrophies, spinocerebellar ataxias, Friedreich’s ataxia, and Huntington’s disease.
Dr. Ashizawa received his medical degree from the Keio University School of Medicine in Tokyo. After moving to the U.S., he completed his neurology residency and Muscular Dystrophy Association fellowships in neurochemistry and clinical neuromuscular disorders at Baylor College of Medicine.
Dr. Ashizawa is board certified in neurology by the American Board of Psychiatry and Neurology. He serves on multiple grant review panels, including NIH study sections, and on the scientific advisory boards of the Myotonic Dystrophy Foundation, the National Ataxia Foundation, and the Association Française contre les Myopathies.
Education/Academic qualification
Neuromuscular Disorders, Fellow, Baylor College of Medicine
1978 → 1979
Neurology, Residency, Baylor College of Medicine
1975 → 1978
Medicine, MD, Keio University School of Medicine
1969 → 1973
Research Area Keywords
- Neurosciences
Fingerprint
Dive into the research topics where Tetsuo Ashizawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (?READISCA?)
6/1/22 → 12/31/22
Project: Federal Funding Agencies
-
Myotonic Dystrophy Compilation of Clinical Findings
Greene, E. P., Appel, S. H., Ashizawa, T., Mathuria, N., Shroff, S. & Thonhoff, J. R.
4/1/20 → …
Project: Clinical Trial
-
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1: END-DM1
Greene, E. P., Ashizawa, T., Shroff, S. & Thonhoff, J. R.
10/8/19 → …
Project: Clinical Trial
-
Genetic mechanism of conserved ancestral haplotype in SCA10
2/1/19 → 12/31/23
Project: Federal Funding Agencies
-
Blood Neurofilament Light Chain in Genetic Ataxia: A Meta-Analysis
Peng, L., Wang, S., Chen, Z., Peng, Y., Wang, C., Long, Z., Peng, H., Shi, Y., Hou, X., Lei, L., Wan, L., Liu, M., Zou, G., Shen, L., Xia, K., Qiu, R., Tang, B., Ashizawa, T., Klockgether, T. & Jiang, H., Jan 2022, In: Movement Disorders. 37, 1, p. 171-181 11 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation
Myotonic Dystrophy Clinical Research Network, May 2022, In: Muscle and Nerve. 65, 5, p. 560-567 8 p.Research output: Contribution to journal › Article › peer-review
-
Comparing loss of balance and functional capacity among patients with SCA2, SCA3 and SCA10
Zonta, M. B., Teive, H. A. G., Camargo, C. H. F., Meira, A. T., Lopes Neto, F. D. N., Tensini, F. S., Braga, C. B., Ashizawa, T. & Munhoz, R. P., Mar 2022, In: Clinical Neurology and Neurosurgery. 214, 107150.Research output: Contribution to journal › Article › peer-review
-
Mechanistic and Therapeutic Insights into Ataxic Disorders with Pentanucleotide Expansions
Zhang, N. & Ashizawa, T., May 1 2022, In: Cells. 11, 9, 1567.Research output: Contribution to journal › Review article › peer-review
Open Access -
Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions
Zhou, Z. D., Jankovic, J., Ashizawa, T. & Tan, E. K., Mar 2022, In: Nature Reviews Neurology. 18, 3, p. 145-157 13 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations
Prizes
-
DNAzymes for cleaving CAG repeat RNA and eliminating viral RNA
Zhang, N. (Recipient) & Ashizawa, Tetsuo (Recipient), Nov 11 2020
Prize: Prize (including medals and awards)